Vertex Pharmaceuticals Inc / Ma

Lansforsakringar Fondforvaltning AB (publ) VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

91,826

Value ($000)

41,630

Weight

0.2%

2024 Q4 - 2025 Q4 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	41,630	0.2%	91,826	12/31/2025
2025 Q3	11/10/2025	57,400	0.3%	146,563	9/30/2025
2025 Q2	8/13/2025	62,902	0.4%	141,290	6/30/2025
2025 Q1	5/14/2025	66,086	0.4%	136,311	3/31/2025
2024 Q4	3/14/2025	58,274	0.7%	144,708	12/31/2024